Tag: Actisave
Acticor Biotech will present the clinical results of its phase 2/3 ACTISAVE study in the treatment of stroke at ESOC 2024 – 04/15/2024 at 6:00 p.m.
To receive all Acticor Biotech financial information in real time, request it by email to [email protected] • Results of the phase 2/3 ACTISAVE clinical study in the treatment of stroke…
Acticor Biotech: recruitment of the 1st patient for the phase 2/3 registration study Actisave
By Alexandra Saintpierre Published on 09/26/2022 at 6:45 p.m. Photo credit © Acticor Biotech …